Two subtypes of optic-spinal form of multiple sclerosis in Japan: Clinical and laboratory features

Journal of Neurology

Volumn 254, Issue 4, 2007, Pages 488-492

  Nakashima, Ichiro ^a   Fukazawa, Toshiyuki ^b   Ota, Kohei ^c   Nohara, Chiyoko ^d   Warabi, Yoko ^e   Ohashi, Takashi ^c   Miyazawa, Isabelle ^a   Fujihara, Kazuo ^a   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nishimaruyama Hospital   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d Department of Dentistry Oral surgery   (Japan)

^e TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

MRI; Multiple sclerosis; Neuromyelitis optica; Optic spinal form

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC SPINAL MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SPINAL CORD LESION;

ADULT; AGED; FEMALE; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NERVE; RETROSPECTIVE STUDIES; SPINAL CORD; STATISTICS, NONPARAMETRIC;

EID: 34249033340     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0400-z     Document Type: Article

References (18)

1. Fukazawa T, Tashiro K, Hamada T, Moriwaka F, Matsumoto A, Shima K, Maruo Y (1992) Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern Med 31:349-352
2. Fukazawa T (1993) Acute transverse myelopathy in multiple sclerosis: clinical and laboratory analyses. Hokkaido Igaku Zasshi 68:79-95
3. Fukazawa T, Kikuchi S, Niino M, Yabe I, Miyagishi R, Fukaura H, Hamada T, Tashiro K, Sasaki H (2004) Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders. J Neurol Sci 225:71-78
4. Kidd D, Thompson AJ, Kendall BE, Miller DH, McDonald WI (1994) Benign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity. J Neurol Neurosurg Psychiatry 57:1070-1072
5. Kikuchi S, Fukazawa T (2005) "OSMS is NMO, but not MS": confirmed by NMO-IgG? Lancet Neurol 4:594-595
6. Kira J, Yamasaki K, Horiuchi I, Ohyagi Y, Taniwaki T, Kawano Y (1999) Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 166:53-57
7. Kira J (2000) A novel feature disclosed in opticospinal multiple sclerosis in Asians. Intern Med 39:272
8. Kira J (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2:117-127
9. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2112
10. Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, Takase S, Itoyama Y (2002) Pure optic-spinal form of multiple sclerosis in Japan. Brain 125:2460-2468
11. Nakashima I, Fujihara K, Takase S, Itoyama Y (1999) Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med 188:89-94
12. Nakashima I, Fujihara K, Sato S, Itoyama Y (2005) Oligoclonal IgG bands in Japanese patients with multiple sclerosis. A comparative study between isoelectric focusing with IgG immunofixation and high-resolution agarose gel electrophoresis. J Neuroimmunol 159:133-136
13. Pittock SJ, McClelland RL, Mayr WT, Jorgensen NW, Weinshenker BG, Noseworthy J, Rodriguez M (2004) Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 56:303-306
14. Saida T, Tashiro K, Itoyama Y, Sato T, Ohashi Y, Zhao Z (2005) Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology 64:621-630
15. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554-558
16. Weinshenker BG (2003) Neuromyelitis optica: what it is and what it might be. Lancet 361:889-890
17. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107-1114
18. Wingerchuk DM, Weinshenker BG (2005) Neuromyelitis Optica. Curr Treat Options Neurol 7:173-182